Notably, the use of a multiple antigen peptide (MAP) approach, which incorporates SmCB1-derived MAP-1 and cathepsins L-derived MAP-2, induced a highly significant protection (~60% worm burden reduction) in S. mansoni -challenged mice [ 56 ].
← all excerpts
Schistosoma japonicum cathepsin L1: A potential target for anti-schistosomiasis strategies.
1
—
—